OVOLIFE Natural cell renewal.

OVOLIFE Natural cell renewal. Reinforce your Brain, Eye, and Immunity in every life stage

  • Close alternative to Mother milk
  • Brain Development
  • Eye Function Development
  • Higher Immunity
  • Non-Allergenicity
  • High Digestibility
  • High Bioavailability
  • Assured Stability
  • High Oxidation Resistance
  • Customized Formulation
  • Neutral Taste And Flavour
  • Dietary Food Emulsifier
  • No Patent Infringements
  • Freedom To Operate
  • Always Recognized As Safe
Contact us

Contact Us

BNLfood International S.A.
1, z.a. Salzbaach - L-9559 WILTZ - Luxembourg
Phone +352 269 556 20
Fax +352 269 556 39

OVOLIFE a Concept of Natural Cell Renewal in every Life Stage

Extracted egg yolk phospholipids OvoLife reinforce functions of the brain, the eyes, and the immune system at all life stages.
OvoLife is a range of completely natural egg derived fatty acids for all life stages, i.e. infancy, adulthood & ageing. OvoLife contains three major functional fatty acids, i.e. docosahexaenoic acid (DHA), arachidonic acid (ARA), and conjugated linoleic acid (CLA), as well other essential nutrients of Choline and Cholesterol, Lutein, Vitamin E. DHA & ARA are the principal omega-3 and omega-6 fatty acids in the brain and the eyes.
Both have several benefits on the ground of proper mental, visual, and immunity development in infants.
CLA is a functional fatty acid involved in fat/muscle metabolism.
Infants, adult health managers and seniors all gain from the addition.
Future developments to enrich egg phospholipids with other nutrients, while keeping the benefits of egg phospholipids, could include CoQ10, Lutein, sterols.

Columbus Concept


The food hypothesis developed by the Columbus Paradigm Institute, suggests that the ideal blood fatty acid pattern in human beings is determined by the following parameter:

ω6:ω3-PUFA = 1:1
%ω6 in LCP = 25

Ovolife Egg Phospholipids stands for the ideal source of dietary essential fatty acids to infants that need to be protected from early inception of chronic degenerative diseases.

Home | Markets & services | Research | Benefits | Press & news | Professionals | Consumers | Intranet | Contact

Privacy Policy | Terms of Use | made by GLUCONE